1. Home
  2. WST vs WRB Comparison

WST vs WRB Comparison

Compare WST & WRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WST
  • WRB
  • Stock Information
  • Founded
  • WST 1923
  • WRB 1967
  • Country
  • WST United States
  • WRB United States
  • Employees
  • WST N/A
  • WRB N/A
  • Industry
  • WST Medical/Dental Instruments
  • WRB Property-Casualty Insurers
  • Sector
  • WST Health Care
  • WRB Finance
  • Exchange
  • WST Nasdaq
  • WRB Nasdaq
  • Market Cap
  • WST 18.9B
  • WRB 28.0B
  • IPO Year
  • WST N/A
  • WRB N/A
  • Fundamental
  • Price
  • WST $257.65
  • WRB $72.81
  • Analyst Decision
  • WST Strong Buy
  • WRB Hold
  • Analyst Count
  • WST 8
  • WRB 11
  • Target Price
  • WST $329.43
  • WRB $71.18
  • AVG Volume (30 Days)
  • WST 552.4K
  • WRB 1.4M
  • Earning Date
  • WST 10-23-2025
  • WRB 10-20-2025
  • Dividend Yield
  • WST 0.35%
  • WRB 2.21%
  • EPS Growth
  • WST N/A
  • WRB 15.81
  • EPS
  • WST 6.68
  • WRB 4.40
  • Revenue
  • WST $2,960,200,000.00
  • WRB $14,286,154,000.00
  • Revenue This Year
  • WST $6.28
  • WRB $9.20
  • Revenue Next Year
  • WST $6.02
  • WRB $7.37
  • P/E Ratio
  • WST $37.92
  • WRB $16.58
  • Revenue Growth
  • WST 2.90
  • WRB 11.41
  • 52 Week Low
  • WST $187.43
  • WRB $55.80
  • 52 Week High
  • WST $352.33
  • WRB $76.38
  • Technical
  • Relative Strength Index (RSI)
  • WST 59.59
  • WRB 56.41
  • Support Level
  • WST $253.38
  • WRB $71.55
  • Resistance Level
  • WST $264.06
  • WRB $74.24
  • Average True Range (ATR)
  • WST 5.62
  • WRB 1.00
  • MACD
  • WST 0.64
  • WRB 0.09
  • Stochastic Oscillator
  • WST 71.41
  • WRB 58.19

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

About WRB W.R. Berkley Corporation

W.R. Berkley is an insurance holding company with a host of subsidiaries that primarily underwrite commercial casualty insurance. The firm specializes in niche products that include various excess and surplus lines, workers' compensation insurance, self-insurance consulting, reinsurance, and regional commercial lines for small and midsize businesses.

Share on Social Networks: